ATP Metabolism as Biomarker Target for Cardiovascular Protection

Cardiovascular Pharmacology: Open Access
doi 10.4172/2329-6607.1000e118
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Osteocalcin as a Potential Risk Biomarker for Cardiovascular and Metabolic Diseases

Clinical Chemistry and Laboratory Medicine
BiochemistryMedicineClinical Biochemistry
2016English

Is High-Density Lipoprotein a Modifiable Treatment Target or Just a Biomarker for Cardiovascular Disease?

JRSM Cardiovascular Disease
2019English

CDK1 Serves as a Potential Prognostic Biomarker and Target for Lung Cancer

Journal of International Medical Research
BiochemistryMedicineCell Biology
2020English

sCLU as Prognostic Biomarker and Therapeutic Target in Osteosarcoma

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2019English

GSK-3β as a Target for Protection Against Transient Cerebral Ischemia

International Journal of Medical Sciences
Medicine
2017English

Introducing Serine as Cardiovascular Disease Biomarker Candidate via Pathway Analysis

Galen Medical Journal
Medicine
2020English

Systematic Approach Identifies RHOA as a Potential Biomarker Therapeutic Target for Asian Gastric Cancer

Oncotarget
Oncology
2016English

C-Met as a Potential Therapeutic Target and Biomarker in Cancer

Therapeutic Advances in Medical Oncology
Oncology
2011English

Arterial Stiffness as a Noninvasive Tissue Biomarker of Cardiac Target Organ Damage

Current Biomarker Findings
BiochemistryClinical Biochemistry
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy